In conclusion, this study suggested that FAM189B was highly expressed in HCC and highly expressed FAM189B may serve as an effective prognostic indicator and a potential therapeutic target for HCC patients. This evidence concerns the gene ENTREP3 and hepatocellular carcinoma.